The contribution of three-dimensional intensity-modulated conformational radiotherapy (IMRT) in the Hodgkin disease: dosimetric study comparing tomo-therapy and three-dimensional conformation radiotherapy

A risk of cancer induced by chemotherapy or radiotherapy has been observed on a long term for patients suffering from the Hodgkin disease. The age at the time of irradiation and a high dose delivered in the breast could be the major risk factors for breast cancers. The authors report the results of the use of an IMRT which reduces these high doses. Notably, the planning target volume (PTV) is significantly better with the IMRT. The authors discuss the volume distribution of low doses for different organs. A long term monitoring is still required to confirm the interest of using IMRT. Short communication